UK Startup Tax Reliefs: The Complete Guide

UK startup tax relief breaks into three groups: investment-side reliefs that incentivise outside capital (SEIS, EIS, VCT), trade-side reliefs that reduce your operating tax (R&D credits, AIA, Patent Box, full expensing), and exit-side reliefs that protect founder wealth on sale (BADR, Investors' Relief). Most growing startups will touch at least one relief from each group across their first five years.

The reliefs do not stack neatly. A SEIS-claiming investor cannot also claim Investors' Relief on the same shares. An R&D claim that uses a grant pushes the qualifying expenditure into the lower-rate RDEC scheme. EMI options have a £250,000 individual limit and a £3 million company limit that interact with EIS share issues. The interactions are the part that requires specialist input; the headline mechanics are public and documented.

What follows is the working framework specialist startup accountants apply when they map a company's reliefs across a 24-month horizon: which to claim now, which to set up for, and which to defer because using one early would block a more valuable one later.

Seed Enterprise Investment Scheme (SEIS) and Enterprise Investment Scheme (EIS) are the two reliefs that most directly shape early-stage UK fundraising. SEIS gives investors 50% income tax relief on up to £200,000 invested per tax year, plus capital gains tax exemption on the eventual sale if held for three years. EIS gives 30% income tax relief on up to £1 million per year (or £2 million for knowledge-intensive companies) with the same CGT exemption.

Most pre-seed and seed UK rounds expect SEIS or EIS eligibility. Investors who cannot claim relief either pass on the round or push the valuation down to compensate, which is why founders frequently discover at term-sheet stage that a structural decision made at incorporation has cost them 30% of dilution. The qualifying conditions cover the company's age (under 7 years for EIS, under 3 for SEIS), gross assets (under £350k for SEIS, under £15m for EIS), employee count, and trading activities.

Advance Assurance from HMRC is the formal pre-clearance most lead investors require. It takes 4–8 weeks and confirms HMRC's view that the company qualifies before investors part with money. Founders who skip Advance Assurance frequently discover post-investment that a single share issuance breach disqualifies the entire round and triggers clawback letters to investors months after the cash has been spent.

R&D tax credits reward UK companies for resolving scientific or technological uncertainty in their work. From April 2024, the previous SME and RDEC schemes merged into a single 20% above-the-line credit (with an enhanced 27% rate for R&D-intensive loss-making SMEs whose qualifying expenditure exceeds 30% of total costs). For most startups, this translates to a cash credit of roughly 16% to 27% of qualifying costs, paid by HMRC against the corporation tax bill or as a refundable credit if the company is loss-making.

Qualifying expenditure includes staff costs, externally-provided workers (with subsidiary rules from April 2024 that mean overseas contractor costs are no longer eligible for most companies), software licences, consumables used up in R&D, and certain cloud computing costs. Salary apportionment is the largest single line item for most claims; technical staff working on qualifying projects can have 100% of their employment costs included if their entire role is R&D, or a documented percentage if part of their work is non-qualifying.

HMRC has been increasingly aggressive on R&D claims since 2023, particularly on software, retail, and consumer-services claims that lack clear technological uncertainty. A specialist accountant who builds the technical narrative and the financial calculation properly is now genuinely the difference between a clean claim and a multi-year HMRC enquiry.

The Annual Investment Allowance (AIA) gives UK companies 100% first-year deduction on up to £1 million of qualifying capital expenditure each year, most plant, machinery, computer equipment, fit-out, and vans. Full expensing (a separate relief, available to companies only) provides 100% deduction on new and unused main-rate plant and machinery without a financial limit, alongside a 50% first-year allowance for special-rate (typically integral building features and long-life assets). Both are now permanent and stack with R&D claims where the asset is also used in qualifying R&D.

Most early-stage startups do not need full expensing because their capital spend stays well within the AIA limit. The relief becomes material when the company starts spending £100k+ on lab equipment, server hardware, or specialist machinery. At that point the structural decisions, whether to buy or lease, whether to capitalise development costs, whether to claim the asset under AIA or under R&D, start to interact materially. Specialist accountants run the comparison; generalists default to AIA without checking whether the structures-and-buildings allowance or full expensing would be more efficient.

Enterprise Management Incentive (EMI) options let qualifying companies grant share options to employees with no income tax or NI on grant or exercise (provided the exercise price is at least the market value at grant), and capital gains taxed at 14% via Business Asset Disposal Relief on eventual sale. For comparable cash compensation, EMI is typically 40-50% more tax-efficient for both the company and the employee, making it the standard equity tool for UK startup hires.

Qualifying conditions cover the company's gross assets (under £30m), employee count (under 250 full-time equivalents), and trading activities. The individual limit is £250,000 of unexercised options per employee at any time; the total company limit is £3 million. Each option grant requires HMRC to value the company at grant date and a notification within 92 days; missing the notification disqualifies the grant entirely.

Setting up an EMI scheme costs £1,500 to £3,500 in professional fees and takes around four to six weeks end to end. Most startups do this at the first hire who needs equity compensation. Generalist accountants frequently miss the 92-day notification deadline or value the shares incorrectly, and the consequences fall on the employee at exercise, usually years later, when the relief is most needed.

Business Asset Disposal Relief (BADR, formerly Entrepreneurs' Relief) reduces capital gains tax to 14% on the first £1 million of qualifying lifetime gains for founders and key employees. Qualifying conditions include holding 5%+ of ordinary shares for 24+ months, holding 5%+ of voting rights, and being an officer or employee throughout the holding period. Founders who restructure share classes, common during investment rounds, frequently lose BADR eligibility without realising, because the new share class no longer satisfies the 5% test.

Investors' Relief covers a similar gap for non-employee investors: 14% CGT on up to £10 million lifetime gains for shares held 36+ months in a qualifying trading company. The two reliefs are mutually exclusive on the same shares; founder-investors who held shares as employees claim BADR, third-party investors who never worked for the company claim Investors' Relief.

At exit, the difference between a 14% rate and a 24% (basic) or 28% (residential property) CGT rate on £1m of gains is £100k–£140k of personal tax. Specialist exit-planning accountants confirm BADR or Investors' Relief eligibility 12–24 months pre-exit, when there is still time to fix any structural issues that would otherwise disqualify the relief.

Patent Box reduces the effective corporation tax rate to 10% on profits attributable to qualifying patents. The relief sits underused in the startup ecosystem because most early-stage companies do not yet have granted patents, and because the calculation requires apportioning company profit across patented and non-patented streams in a way generalist accountants find intimidating.

For deep-tech and life-sciences startups with granted patents protecting product revenue, Patent Box is materially valuable. A company with £2m of profit driven by a patented product structure could save £300k+ per year in corporation tax. The administrative work, computing the streamed profit, the routine return on costs, and the marketing-asset deduction, is non-trivial but a specialist accountant can complete it in 5–10 hours of work per year.

The trigger to start setting up for Patent Box is patent grant or even just patent filing in cases where the IP will protect a material revenue stream. Companies that anticipate patenting in the next 18 months should structure their accounting to capture the costs that will eventually feed the Patent Box calculation, rather than trying to reconstruct them retroactively.